Experiences of patients with age-related macular degeneration receiving anti-vascular endothelial growth factor therapy: A qualitative study.

BURTON, Amy, Shaw, Rachel and Gibson, Jonathan (2013) Experiences of patients with age-related macular degeneration receiving anti-vascular endothelial growth factor therapy: A qualitative study. British Journal of Vision Impairment, 31 (3). pp. 178-188.

Preview

Text eprint1187.pdf - AUTHOR'S ACCEPTED Version (default) Available under License All Rights Reserved. Download (201kB) | Preview

Abstract or description

The societal cost for the average health authority in the UK for the care of wet age related macular degeneration (AMD) has been suggested to be around £7.4 million. It is vital the best possible care based on the best available evidence is provided to reduce the impact of AMD on patients’ lives and the financial cost to the health care system. This study explored the experiences of AMD patients treated with intravitreal ranibizumab injections. Three semi-structured interviews were conducted with seven participants over the course of 18 months. Transcripts were analysed using interpretative phenomenological analysis. Analysis identified four themes: preparing for treatment, the treatment process, patient-provider communication and results of treatment. Patient experiences highlighted the need to move away from the reliance on letters for information provision, and the need for clearer guidelines about when to cease AMD treatment. Interviews highlighted the need for the inclusion of rigorous qualitative evidence with experiential data in future good clinical practice guideline development for AMD.

Item Type:	Article
Faculty:	Previous Faculty of Health Sciences > Psychology, Sport and Exercise
Depositing User:	Amy BURTON
Date Deposited:	29 May 2013 10:56
Last Modified:	24 Feb 2023 13:38
URI:	https://eprints.staffs.ac.uk/id/eprint/1187

Actions (login required)

View Item